Man Group »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Man Group

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Man Group from 13F filings

Historical chart of Man Group investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Man Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Man Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.8M 2.4M 1.19
2024-06-30 $3.1M 2.8M 1.11
2024-03-31 $3.5M 3.6M 0.97
2023-12-31 $3.6M 3.8M 0.93
2023-09-30 $3.6M 3.9M 0.94

More positions owned by Man Group

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Amphenol Corp Cl A (APH)
Mastercard Incorporated Cl A (MA)
Qualcomm (QCOM)
Merck & Co (MRK)
Motorola Solutions Com New (MSI)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Man Group

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1